ClinicalTrials.Veeva

Menu

Development and Piloting an Avatar-based Intervention to Support Patients Undergoing Stem Cell Transplantation

Dana-Farber Cancer Institute logo

Dana-Farber Cancer Institute

Status

Completed

Conditions

Hematopoietic Cell Transplantation

Treatments

Behavioral: Care.Coach

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT05600101
R44CA236253 (U.S. NIH Grant/Contract)
22-412

Details and patient eligibility

About

The goal of this research study is to provide an avatar-based technology during a subject's stay for participants who have been admitted to the hospital for reduced-intensity conditioning (RIC) allogeneic transplant. The intervention received will be the care.coach technology.

Full description

This research study is a Pilot Study, which means the investigators are studying the application in a smaller group of people to understand whether the technology, care.coach, is easy to use.

This is a single site study at Dana-Farber Brigham and Women's Cancer Center.

  • Aim 1 of the study will be an 8 - 10 participant focus group of nurses, navigator nurses, physicians, and NPs/PAs to refine the avatar protocols.

  • Aim 2 of the study will be a pilot of 18 participants undergoing RIC allogeneic HCT in the hospital.

    • The research study procedures include screening for eligibility, a brief call with a research assistant during use of care.coach avatar, and a survey after study completion.
    • The avatar is designed to communicate with participants regarding transplantation education and provide reminders for eating, drinking, and activity.
    • care.coach is a digital, avatar-based technology that communicates using natural speech software.
    • care.coach is supporting this research by providing Dana-Farber access to its technology. The National Cancer Institute (NCI) also supports this research.

Enrollment

18 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria for HCT focus group:

  • Age 18+.
  • DFCI/HCC HCT nurse navigators, inpatient HCT nurses, and HCT physicians and extenders (NP/PA).

Inclusion Criteria for care.coach pilot:

  • Age 18+.
  • Admitted for reduced-intensity conditioning (RIC) allogeneic HCT

Exclusion Criteria for care.coach pilot:

Deemed by clinical staff or RA to be unable to converse with an avatar, due to:

  • Severe, uncorrectable hearing impairment and simultaneous severe, uncorrectable vision impairment.
  • Severe speech impairment that precludes understanding by staff (and by extension, by the avatar).
  • Not fluent in English.

Trial design

Primary purpose

Supportive Care

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

18 participants in 1 patient group

care.coach Pilot
Experimental group
Description:
The research study procedures include screening for eligibility, a brief call with a research assistant after tablet is given to subject, and a survey after a subject has completed the study. * 3 consecutive cohorts of 6 RIC HCT patients each. * care.coach is a "human-in the-loop" conversational agent (avatar) used to interact and converse with patients through natural dialogue and text-to-speech software that is powered by a team of trained human staff, called health advocates. A subject uses the avatar for up to 3 weeks.
Treatment:
Behavioral: Care.Coach

Trial documents
2

Trial contacts and locations

2

Loading...

Central trial contact

Gregory Abel, MPH, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems